Fidelity SPDR Advertisement
Home > Boards > US OTC > Biotechs > Bio-Matrix Scientific Group Inc. (BMSN)

BMSN in ihub breakout board

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
l2 hunter Member Profile
Member Level 
Followed By 2,664
Posts 78,589
Boards Moderated 7
Alias Born 02/21/11
160x600 placeholder
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/13/2014 3:58:15 PM
Bio-Matrix Scientific Group Inc. Subsidiary Regen BioPharma Inc. Collaborates on Research Paper Analyzing the Use of Gene Sil... "Marketwired" - 6/11/2014 10:00:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/13/2014 9:38:36 AM
Regen BioPharma, a Majority Owned Subsidiary of Bio-Matrix Scientific Group, Provides Update on HemaXellerate I(TM) IND for T... "Marketwired" - 5/12/2014 12:30:06 PM
Bio-Matrix Scientific Group Inc. Announces Dividend Record Date to Receive Shares in Its Subsidiary Regen BioPharma, Inc. "Marketwired" - 3/6/2014 2:53:06 PM
Amended Annual Report (10-k/a) "Edgar (US Regulatory)" - 2/12/2014 6:05:57 AM
Amended Quarterly Report (10-q/a) "Edgar (US Regulatory)" - 2/10/2014 1:00:01 PM
Amended Current Report Filing (8-k/a) "Edgar (US Regulatory)" - 2/10/2014 12:55:48 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 2/6/2014 3:04:54 PM
Regen BioPharma Announces HemaXellerate I(TM) Efficacy Data in Animal Model of Aplastic Anemia "Marketwired" - 12/11/2013 9:35:00 AM
Bio-Matrix Scientific Group's Regen BioPharma Retains Cook General Biotechnology for Contract Manufacturing of HemaXellerate I "Marketwired" - 10/31/2013 11:35:55 AM
Semi-annual Report (management Company) (nsar-a/a) "Edgar (US Regulatory)" - 10/9/2013 3:45:22 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/9/2013 3:45:22 PM
Bio-Matrix Scientific Group Inc. Announces 20 Million Share Regen BioPharma Dividend to Be Paid to Shareholders "Marketwired" - 10/9/2013 3:11:17 PM
Designate a New Effective Date for a Post-effective Amendment Previously Filed Pursuant to Rule 485(a) (485bxt) "Edgar (US Regulatory)" - 10/1/2013 6:03:09 AM
Designate a New Effective Date for a Post-effective Amendment Previously Filed Pursuant to Rule 485(a) (485bxt) "Edgar (US Regulatory)" - 10/1/2013 6:03:09 AM
Amended Certified Annual Shareholder Report for Management Investment Companies (n-csr/a) "Edgar (US Regulatory)" - 10/1/2013 6:03:07 AM
Amended Certified Annual Shareholder Report for Management Investment Companies (n-csr/a) "Edgar (US Regulatory)" - 10/1/2013 6:03:07 AM
Amended Certified Annual Shareholder Report for Management Investment Companies (n-csr/a) "Edgar (US Regulatory)" - 10/1/2013 6:03:06 AM
Amended Certified Annual Shareholder Report for Management Investment Companies (n-csr/a) "Edgar (US Regulatory)" - 10/1/2013 6:03:06 AM
Amended Certified Annual Shareholder Report for Management Investment Companies (n-csr/a) "Edgar (US Regulatory)" - 10/1/2013 6:03:06 AM
Amended Certified Annual Shareholder Report for Management Investment Companies (n-csr/a) "Edgar (US Regulatory)" - 10/1/2013 6:02:46 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/1/2013 6:02:45 AM
Bio-Matrix Scientific Group's Subsidiary Regen BioPharma Enters Into Preclinical Trials Agreement for HemaXellerate I Coverin... "Marketwired" - 9/26/2013 8:00:00 AM
Bio-Matrix Scientific Group's Subsidiary, Regen BioPharma Announces dCellVax Breast Cancer Immunotherapeutic Product "Marketwired" - 9/25/2013 8:30:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist